Lam Wendy W T, Fielding Richard, Ho Ella Y Y, Chan Miranda, Or Amy
Department of Nursing studies, University of Hong Kong, People's Republic of China.
Psychooncology. 2005 Jul;14(7):585-93. doi: 10.1002/pon.877.
to identify factors influencing Chinese women's choices between breast-conserving therapy (BCT), mastectomy (MRM) or MRM followed by breast reconstruction (MRM+R).
of 405/443 Hong Kong Chinese women receiving surgery for early breast cancer who were interviewed one week post-surgery about their pre-surgical consultation, available treatment alternatives, whether their surgeons had indicated a surgical preference, perceived efficacy of the surgical options and considerations influencing their treatment decisions (TDM), 198 (49%) reported they were offered a choice of surgery.
among women offered a choice of surgery, BCT was chosen by 34/43 (79%) of women whose surgeons recommended BCT but by only 34/96 (37%) of women whose surgeons expressed no treatment recommendation. Multivariate adjustment showed women choosing MRM were influenced more by avoiding both cancer recurrence (p = 0.003) and further treatment (p = 0.009) when choosing surgical option than women choosing BCT. In contrast, women choosing MRM+R and BCT, placed more emphasis on appearance (p < 0.001) and body image (p < 0.001) concerns as influencing treatment choice than did women who chose MRM.
survival concerns rather than physical appearance, age and lack of recommendation push Chinese women to choose MRM as BCT is, incorrectly often seen as less efficacious. Recommending BCT increases BCT choice.
确定影响中国女性在保乳治疗(BCT)、乳房切除术(MRM)或乳房切除术后乳房重建术(MRM+R)之间选择的因素。
在443名接受早期乳腺癌手术的中国香港女性中,有405名在术后一周接受了访谈,内容涉及她们术前咨询的情况、可用的治疗方案、外科医生是否表明了手术偏好、对手术方案疗效的认知以及影响其治疗决策(TDM)的因素。其中198名(49%)报告称她们有手术选择。
在有手术选择的女性中,外科医生推荐BCT的女性中有34/43(79%)选择了BCT,但外科医生未给出治疗建议的女性中只有34/96(37%)选择了BCT。多变量调整显示,与选择BCT的女性相比,选择MRM的女性在选择手术方案时,更受避免癌症复发(p = 0.003)和进一步治疗(p = 0.009)的影响。相比之下,与选择MRM的女性相比,选择MRM+R和BCT的女性在影响治疗选择方面更强调外观(p < 0.001)和身体形象(p < 0.001)问题。
生存担忧而非外貌、年龄和缺乏建议促使中国女性选择MRM,因为BCT常常被错误地认为疗效较差。推荐BCT会增加BCT的选择。